Gliadel wafers in the treatment of malignant glioma: a systematic review.
about
Chemotherapy wafers for high grade gliomaPharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapyIntratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapyEvolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance.HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea.Single compartment drug delivery.Synthesis and Self-Assembly of a Mikto-Arm Star Dual Drug Amphiphile Containing both Paclitaxel and Camptothecin.The future of high-grade glioma: Where we are and where are we going.Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma.Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide.Prevention of lung cancer recurrence using cisplatin-loaded superhydrophobic nanofiber meshes.Self-assembly of cytotoxic peptide amphiphiles into supramolecular membranes for cancer therapy.Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies.Glioblastoma multiforme therapy and mechanisms of resistance.Assessing response using 99mTc-MIBI early after interstitial chemotherapy with carmustine-loaded polymers in glioblastoma multiforme: preliminary results.Histopathological correlates with survival in reoperated glioblastomas.Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: report of two cases and review of literature.DC Bead embolic drug-eluting bead: clinical application in the locoregional treatment of tumours.Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.Convergence technology in cancer medicine.Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors.The spectrum of vaccine therapies for patients with glioblastoma multiformeAdvances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy.RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.Biomaterial-Based Implantable Devices for Cancer Therapy.Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.Interstitial chemotherapy for malignant glioma: Future prospects in the era of multimodal therapySurvival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.Biodegradable implants efficiently deliver combination of paclitaxel and temozolomide to glioma C6 cancer cells in vitro.Anticancer potential of aminomethylidene-diazinanes I. Synthesis of arylaminomethylidene of diazinetriones and its cytotoxic effects tested in glioblastoma cells.Localized targeted antiangiogenic drug delivery for glioblastoma.Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.Glioblastoma Treatments: An Account of Recent Industrial DevelopmentsIn vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatmentAdverse Event with the Use of Carmustine Wafers and Postoperative Radiochemotherapy for the Treatment of High-grade Glioma
P2860
Q24235641-111D0649-60D6-46B4-9BC2-D3B1E761B849Q27300391-BF39633C-B03D-4FED-9339-7AAF5C110F3BQ28078486-50A9A3C1-B799-49B8-A761-2009599100DEQ33753357-138DFB9E-2BF3-407D-BB08-E1BB6DF2AE80Q33923950-F994A1EC-8A28-4234-9028-1D9EFBB7692AQ34006181-7EEF0891-97E1-4CF2-B5BF-AEFF692DB367Q34133124-CDD81D25-C310-4792-95C0-7E25DBAEE91EQ34263907-785EC394-464F-4CBD-B7CC-E779BD8181B7Q35057136-4F2EC526-1B05-4AC1-8C7C-B22156E2EF7BQ35114090-B22E8A96-7077-4A1C-B369-D319378D4DD7Q35758314-B8331CC7-1065-4F50-846F-F3E6169621EBQ36357995-D76F9771-193A-4A30-83E8-1736D21B2FD6Q36682970-0AFCACF8-AF03-4046-8734-BABFB81545CCQ36923108-356D49BB-E985-4088-AAB2-D5D3587E1CE2Q37283351-604083D9-0998-4324-9E78-C6DB128319D4Q37415954-571512B9-D9D7-4CF5-8E77-92DCE9A317BAQ37700540-872F17E9-26EA-4CBA-8FBA-66C3ED37B648Q37714899-A475E237-7FAE-4F10-9939-DA1BA5521DA5Q37793068-2BB35D5D-8397-4EAC-A125-E62A4BE6907DQ37827492-268795D8-C905-473E-A54F-6ED99D70C32EQ37845396-77F1061D-6D87-4AA3-AFBC-D0B85D0476A9Q37850452-83525F15-AC15-44BE-98DD-103A5979F957Q37908136-372EB8A9-DDA4-49CE-8361-68EB77267A94Q38035788-27D97F11-4B1F-4177-85CA-15D7B93943E3Q38227489-4685B2CE-CF27-4657-8247-C252DDC807CBQ38541950-23832985-D013-4468-98F7-4EB9E7FC1B72Q38790816-06DD1C02-7C7F-4A30-8C2E-CAF86ECE3999Q38867048-914F3D3C-F9F0-4D52-9EB3-BB953B7E1995Q38883374-99806EAD-D521-4604-AB80-100357973337Q39034877-EF185B78-69C7-41E7-9BB0-4711E03C454BQ39046974-215DDABB-73EB-44B9-886F-95F74BC22D76Q39098198-3D6BAFA2-B7CD-4D15-9741-8A86F270FBC4Q47726633-A2A36DC8-34BF-4D24-8CF4-C219262EB11AQ47736401-8FCA4BDE-847F-43AE-900D-AACED68E9B95Q50090153-63EAEC5F-54DB-463D-8407-7B1FF6927FD9Q57111067-88320DDD-4F29-49FE-9DFA-9AB1C2667AA7Q57214335-B8B3B345-1479-4AE4-8647-11B6EE5065A7Q59128662-FB8254CB-105C-40BF-A520-00E760156C69
P2860
Gliadel wafers in the treatment of malignant glioma: a systematic review.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@ast
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@en
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@nl
type
label
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@ast
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@en
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@nl
prefLabel
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@ast
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@en
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@nl
P2093
P2860
P356
P1433
P1476
Gliadel wafers in the treatment of malignant glioma: a systematic review.
@en
P2093
A Chambers
K Spithoff
N Laperriere
P2860
P304
P356
10.3747/CO.2007.147
P577
2007-10-01T00:00:00Z